Table 2.
Odds ratio for metabolic syndrome by multivariable logistic regression analysis of fibroblast growth factor 21 levels among the 126 patients with type 2 diabetes mellitus.
| FGF21 (pg/mL) | Unadjusted | Model 1 | Model 2 | Model 3 | ||||
|---|---|---|---|---|---|---|---|---|
| OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | |
| Per 1 pg/mL | 1.008 | 0.001∗ | 1.007 | 0.004∗ | 1.005 | 0.027∗ | 1.005 | 0.035∗ |
| FGF21 increase | (1.003–1.012) | (1.002–1.011) | (1.001–1.010) | (1.000–1.010) | ||||
Model 1 is adjusted for age and gender. Model 2 is adjusted for the Model 1 variables and for estimated glomerular filtration rate and urine albumin-to-creatinine ratio. Model 3 is adjusted for the Model 2 variables and for insulin level and homeostasis model assessment of insulin resistance. ∗P < 0.05 by multivariate logistic regression analysis. FGF21, fibroblast growth factor 21; OR, odds ratio; CI, confidence interval.